Although the second-generation assay may overestimate the severity of hyperparathyroidism in patients with CKD, especially in individuals with severe SHPT, it still is recommended for detecting circulating PTH levels by the KDIGO guidelines [36], probably because currently available clinical evidence about (1-84) PTH is rather limited compared to that of iPTH values. Here, PTH is linked to hyperparathyroidism.